Impilo Orphan Drugs AB — Form D
Impilo Orphan Drugs AB of STOCKHOLM, V7, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2024-09-30. $80.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-09-30
- Form: D
- Accession: 0001315863-24-000688
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $80.5M
- Investors: 12
- Date of first sale: 2024-09-19
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-525326
Issuer
- Name: Impilo Orphan Drugs AB
- CIK: 0002037323
- Entity type: Other
- Jurisdiction: SWEDEN
- Incorporated: 2024
- Address: REGERINGSGATAN 48, STOCKHOLM, V7, SE-111 56
- Phone: 46 70943 23 30
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Tor Ulf Edvard Hubendick | Director | Stockholm, V7 |
| Karl Gustav Johan Fredrik Jungdalen Lundgren | Director | Stockholm, V7 |
| Johan Fredrik Odin | Director | Stockholm, V7 |
| N/A Impilo Holding AB | Promoter | Stockholm, V7 |
More